Cerity Partners LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,673,463
+3.9%
253,232
-1.9%
0.05%
+30.6%
Q2 2023$9,310,425
-4.6%
258,121
+1.0%
0.04%
+56.5%
Q1 2023$9,760,906
-33.8%
255,588
-1.4%
0.02%
-75.5%
Q4 2022$14,753,033
+5467.2%
259,280
+3769.9%
0.09%
+3033.3%
Q3 2022$265,000
+1.1%
6,700
+12.5%
0.00%0.0%
Q2 2022$262,0005,9530.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders